tiprankstipranks
Trending News
More News >
Biostax (BTAX)
OTHER OTC:BTAX
US Market

Biostax (BTAX) Financial Statements

Compare
11 Followers

Biostax Financial Overview

Biostax's market cap is currently $15.74K. The company's EPS TTM is $-0.022; its P/E ratio is ―; Biostax is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -1.48M$ -1.16M$ -738.17K$ -887.03K$ -2.84M
EBITDA$ -1.47M$ -3.42M$ 3.83M$ 2.23M$ -2.02M
Net Income$ -1.65M$ -3.54M$ 3.59M$ 1.59M$ -3.40M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 743.48K$ 963.72K$ 3.14M$ 10.17K$ 5.82K
Total Debt$ 1.18M$ 696.48K$ 3.07M$ 2.84M$ 5.55M
Net Debt$ 1.15M$ 545.99K$ -68.68K$ 2.83M$ 5.54M
Total Liabilities$ 3.45M$ 3.09M$ 11.09M$ 11.68M$ 13.69M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -656.53K$ -1.08M$ -231.72K$ -191.96K$ -934.00
Operating Cash Flow$ -656.53K$ -581.82K$ -231.72K$ -191.96K$ -934.00
Investing Cash Flow
Financing Cash Flow
Currency in USD

Biostax Earnings and Revenue History

Biostax Debt to Assets

Biostax Cash Flow

Biostax Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis